Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
Imaging Studies IV: Magnetic Resonance Imaging01:27

Imaging Studies IV: Magnetic Resonance Imaging

Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intensified Rituximab, Methotrexate, Procarbazine, and Cytarabine (R-MPVA) Regimen With Sequential Addition of Etoposide to R-MPV and Ifosfamide to R-AraC for Newly Diagnosed Primary CNS Lymphoma Patients Aged Between 60 and 70 Years: An LOC Network Study.

Hematological oncology·2026
Same author

GABA promotes resistance to immunotherapy in patients with TLS-positive tumors.

Cancer cell·2026
Same author

Towards routine biomechanical data collection in stroke rehabilitation: a usability comparison of IMU and markerless motion capture systems for functional upper-limb assessments.

Journal of neuroengineering and rehabilitation·2026
Same author

Radiological and FDG-PET imaging features of Epstein-Barr virus-positive primary central nervous system lymphomas.

Journal of neurology·2026
Same author

Prognostic impact of Dmax on baseline FDG-PET/CT in newly diagnosed multiple myeloma.

Haematologica·2026
Same author

High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Related Experiment Video

Updated: Jul 20, 2026

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.8K

Automatic Segmentation of Primary Central Nervous System Lymphoma at Clinical Routine Postcontrast T1-weighted MRI.

Guanghui Fu1, Lucia Nichelli1,2, Darío Herrán de la Gala2

  • 1Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, CNRS, Inria, Inserm, AP-HP, Hôpital de la Pitié Salpêtrière, 47 Boulevard de l'Hôpital, 75013 Paris, France.

Radiology. Imaging Cancer
|September 19, 2025
PubMed
Summary

A deep learning model accurately segments primary central nervous system lymphoma (PCNSL) on MRI scans. This artificial intelligence tool shows robust performance across multiple centers, aiding brain tumor diagnosis.

Keywords:
Artificial IntelligenceAutomatic SegmentationBrain LymphomaBrain TumorDeep Learning

More Related Videos

Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images
06:48

Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images

Published on: January 7, 2019

9.4K
Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies
04:25

Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies

Published on: December 15, 2023

3.8K

Related Experiment Videos

Last Updated: Jul 20, 2026

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.8K
Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images
06:48

Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images

Published on: January 7, 2019

9.4K
Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies
04:25

Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies

Published on: December 15, 2023

3.8K

Area of Science:

  • Radiology and Medical Imaging
  • Artificial Intelligence in Medicine
  • Oncology

Background:

  • Primary central nervous system lymphoma (PCNSL) is a rare brain tumor requiring accurate segmentation for treatment planning.
  • Manual segmentation of PCNSL on MRI is time-consuming and subject to inter-observer variability.
  • Deep learning offers potential for automated and standardized segmentation of brain tumors.

Purpose of the Study:

  • To develop and validate a deep learning model for automatic segmentation of PCNSL using postcontrast T1-weighted MRI.
  • To assess the model's performance and robustness across internal and external datasets from multiple clinical centers.

Main Methods:

  • Retrospective collection of data from patients with pathologically proven immunocompetent PCNSL.
  • Training and validation of a deep learning model using the nnU-Net framework on postcontrast T1-weighted MRI scans.
  • Performance evaluation using Dice score, mean average surface distance, and F1 score, with comparisons using Mann-Whitney U test and bootstrap resampling.

Main Results:

  • The deep learning model achieved high performance with a mean Dice score of 0.84 (internal) and 0.88 (external).
  • Strong volumetric correlation (r=0.99 internal, r=0.98 external) was observed between automatic and manual segmentations.
  • Model performance was consistent across multiple centers, despite variations in MRI acquisition parameters.

Conclusions:

  • A deep learning model provides accurate and robust automatic segmentation of PCNSL.
  • This AI-driven approach has the potential to standardize PCNSL segmentation and improve diagnostic workflows.
  • The model demonstrates generalizability across different clinical settings for brain tumor analysis.